Search results
Sutro Biopharma shares hold on luvelta prospects By Investing.com
Investing.com· 2 days agoThe biopharmaceutical firm has completed enrollment for part one of the REFRaME-01 study, which...
Capsida Biotherapeutics to Present Preclinical Data for Parkinson's Disease Associated with GBA...
KTLA-TV Los Angeles· 6 days agoCapsida Biotherapeutics ("Capsida") today announced new preclinical data that demonstrate the potential of its next-generation intravenously (IV) administered gene therapy candidate, CAP-003 ...
Are You Looking for a High-Growth Dividend Stock?
Zacks· 15 hours agoWhile cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings ...
Nipocalimab's Unique Mechanism Gets Second Chance in RA
Medscape· 4 days agoThe IRIS-RA study of the investigational monoclonal antibody drug nipocalimab in patients with...
NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis
Clinical Trials Arena via Yahoo Finance· 1 day agoPhaseV will analyse NeuroSense’s Phase II ALS trial data, and results from these will inform Phase...
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks· 7 days agoFree Report) reported the death of a young boy who participated in a mid-stage study of its Duchenne muscular dystrophy (“DMD”) drug, fordadistrogene movaparvovec. An FDA ...
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 6 days agoIronwood (IRWD) incurs loss in the first quarter of 2024. Revenues decline year over year and miss...
Patient Preferences Drive Treatment Options for Early HS
Medscape· 4 days agoTreatment options for individuals with early-stage hidradenitis suppurativa (HS) vary depending on...
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks· 7 days agoThe top line decreased almost 28% year over year due to a $30.0 million gross-to-net change in estimate for the sole marketed drug, Linzess (linaclotide), recorded to collaborative arrangements ...
In RA Treatment, Don't Overlook Underlying CV Risks
Medscape· 15 hours agoPatients with rheumatoid arthritis (RA) carry a high risk for cardiovascular events, but mounting clinical evidence suggests they're being undertreated...
